Using molecular components of stem cells to enhance the brain's ability
to rebuild the brain after a stroke holds good promise in treating long
term disability in adults. Michael Chopp, Ph.D., Scientific Director of
the Henry Ford Neuroscience Institute, will presentthis approach to
treating neurological diseases Thursday, Feb. 13, at the American
HeartAssociation's International Stroke Conference in San Diego.
Although most stroke victims recover some ability to voluntarily use
their hands and other bodyparts, half are left with weakness on one side
of their body, and a substantial number arepermanently disabled. No
treatment currently exists for improving or restoring this lost motor
function in strokepatients, mainly because of mysteries about how the
brain and nerves repair themselves.But Dr. Chopp and other Henry Ford
scientists may have solved some of these mysteries throughexperiments at
the molecular level identifying and testing components of stem cells.
"Even in older people, the central nervous system is highly plastic, meaning it has a unique abilityto change and rebuild itself," Dr. Chopp explains. "We have demonstrated that this plasticity can bestimulated to promote neurological recovery after a stroke."One such therapy involves proteins that shape the developing brain, specifically a type thatreleases tissue plasminogen activator, or tPA, which causes axons and dendrites - the brain's neuralcables and communications network - to rewire.
"We have shown that administering tPA in a nasal spray promotes this rewiring and significantlyenhances neurological recovery," Dr. Chopp says.Dr. Chopp will also speak at the AHA conference about other microscopic material in stem cellscalled exosomes that offer a "robust" treatment for stroke's crippling effects.These blister-like microscopic "bubbles" were once were thought to carry and get rid of "old"proteins that were no longer needed by the body.
However, exosomes were recently found to provide anessential form of "communication" between brain cells using "packages" sent out by stem cells withvital directions for gene regulation.This is done through microRNA, master molecular switches that alter brain cells and promote recoveryfrom trauma. Dr. Chopp and his team have shown and confirmed that stem cell therapy works by firing off these"information bullets."But they have also shown that neurological diseases can be treated with exosomes alone, separatefrom stem cells."This approach may be a revolutionary way to successfully treat stroke and many other diseases," Dr.Chopp says.
Source: American HeartAssociation's International Stroke Conference in San Diego.
"Even in older people, the central nervous system is highly plastic, meaning it has a unique abilityto change and rebuild itself," Dr. Chopp explains. "We have demonstrated that this plasticity can bestimulated to promote neurological recovery after a stroke."One such therapy involves proteins that shape the developing brain, specifically a type thatreleases tissue plasminogen activator, or tPA, which causes axons and dendrites - the brain's neuralcables and communications network - to rewire.
"We have shown that administering tPA in a nasal spray promotes this rewiring and significantlyenhances neurological recovery," Dr. Chopp says.Dr. Chopp will also speak at the AHA conference about other microscopic material in stem cellscalled exosomes that offer a "robust" treatment for stroke's crippling effects.These blister-like microscopic "bubbles" were once were thought to carry and get rid of "old"proteins that were no longer needed by the body.
However, exosomes were recently found to provide anessential form of "communication" between brain cells using "packages" sent out by stem cells withvital directions for gene regulation.This is done through microRNA, master molecular switches that alter brain cells and promote recoveryfrom trauma. Dr. Chopp and his team have shown and confirmed that stem cell therapy works by firing off these"information bullets."But they have also shown that neurological diseases can be treated with exosomes alone, separatefrom stem cells."This approach may be a revolutionary way to successfully treat stroke and many other diseases," Dr.Chopp says.
Source: American HeartAssociation's International Stroke Conference in San Diego.
No comments:
Post a Comment